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Abstract
Background: Chronic granulomatous disease (CGD) is an inherited disorder of phagocytic cells
caused by an inability to generate active microbicidal oxygen species required kill certain types of
fungi and bacteria. This leads to recurrent life-threatening bacterial and fungal infections with tissue
granuloma formation.
Case presentation: We describe a case of X-linked Chronic granulomatous disease (CGD)
diagnosed in an 18-year-old male. He initially presented with granulomatous disease mimicking
sarcoidosis and was treated with corticosteroids. He subsequently developed Burkholderia cepacia
complex pneumonia and further investigation confirmed a diagnosis of CGD.
Conclusion: Milder phenotypes of CGD are now being recognised. CGD should be considered
in patients of any age with granulomatous diseases, especially if there is a history of recurrent or
atypical infection.
Background
Chronic granulomatous disease (CGD) is an inherited
disorder of phagocytic cells resulting in an inability of
phagocytes to undergo the respiratory burst required kill
certain types of fungi and bacteria. This leads to recurrent
life-threatening bacterial and fungal infections as well as
persistent tissue granuloma formation. It was initially
described in the 1950s as a syndrome of recurrent infec-
tions, hypergammaglobulinemia, hepatosplenomegaly,
and lymphadenopathy in boys who invariably died in the
first decade of life [1]. The majority of cases are detected
before the age of five, with 90% detected before the age of
fifteen with the diagnosis usually considered due to a his-
tory of recurrent, unusual or persistent infections. CGD is
caused by mutations in components of the NADPH oxi-
dase system. Identification of this defect has allowed
milder phenotypes to be identified which may be associ-
ated with milder disease or atypical features resulting in
subsequent delay in presentation and diagnosis until
adulthood [2-4].
Case presentation
A 21-year-old gentleman initially was referred with weight
loss, fevers and hepatosplenomegaly. He had previously
been investigated for lymphadenopathy. A left inguinal
lymph node excision 3 years earlier had shown "unusual
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histology, possibly reactive or due to a low-grade lym-
phoma" and a decision for close follow up was made. A
second lymph node biopsy was performed 1 year later for
persistent right cervical and right inguinal lymphadenop-
athy. Histology showed granulomatous lymphadenitis,
again with unusual histology, reported as "possibly due to
sarcoid or reactive secondary to infection". At this time he
was also noted to have hepatosplenomegaly, abnormal
liver function and pancytopenia. A liver biopsy was per-
formed prior to referral showing abnormal architecture,
lymphoid proliferation and multiple non-caseating epi-
theliod granulomas.
On examination he was pale with low-grade pyrexia of
37.5°C. Cardiovascular and respiratory examinations
were normal, but he had cervical lymphadenopathy.
Abdominal examination revealed massive hepat-
osplenomegaly without ascites. Computed Tomography
of the chest and abdomen showed hepatosplenomegaly
with mediastinal and para-aortic lymphadenopathy sus-
picious of lymphoma. Pulmonary function testing
showed decrease in diffusion capacity. Liver function and
full blood count were abnormal (Table 1). Serum ACE
(angiotensin converting enzyme) was raised at 80 U/L
(normal range 8–52). Other bloods including liver screen,
autoimmune screen and virology screen were all negative.
A clinical diagnosis of sarcoidosis was made and he was
commenced on steroid treatment with prednisolone 40
mg daily. Within two days his pyrexia settled, his liver
function improved and his splenomegaly improved. He
was discharged home on 20 mg prednisolone. Over the
next twenty-four months, his liver function continued to
improve and the patient remained clinically well. How-
ever, his pancytopenia worsened and a bone marrow
biopsy revealed normal haematopoesis with a few non-
caseating granulomas. The pancytopenia was felt to be
due to hypersplenism and the decision was made for him
to undergo splenectomy.
During admission for splenectomy the patient com-
plained of cough and was noted to be pyrexial and tachy-
cardic. A chest radiograph revealed left basal
consolidation with right basal changes. Despite a two-
week course of moxifloxacin he remained symptomatic
with cough, night sweats, fevers up to 40°C and was noted
to be hypoxic. Computed Tomography of the thorax
showed mediastinal lymphadenopathy with extensive
consolidation, and a lung biopsy showed non-specific
inflammation. Microbiological culture of the biopsy spec-
imen grew a bacteria belonging to the Burkholderia cepacia
complex, Burkholderia multivorans which was subsequently
confirmed on broncho-alveolar lavage.
In light of the unusual organism, the histology was
reviewed and the possibility of chronic granulomatous
disease was raised. Neutrophil burst test (Figure 1b)
showed impaired neutrophil oxidative burst consistent
with CGD. Western blot showed decreased expression of
the gp91phox protein consistent with X-linked CGD (Fig-
ure 2). His mother and sister were also tested and found
to be carriers as evidenced by dual population of normal
and abnormal neutrophils (Figure 1c). Genetic analysis
confirmed a mutation in exon 9 of the gp91phox gene. The
patient was treated with cotrimoxazole and commenced
on prophylactic itraconazole. He made a good clinical
improvement and was discharged nine days later on pro-
phylactic antibiotics and antifungals. The steroid dose was
gradually tapered down. His splenomegaly has gradually
improved with the spleen decreasing in size from 24 cm
to 18 cm. The haemoglobin and platelet counts returned
to normal. His lymphocytes remained low probably
reflecting continued enlarged spleen. and after 18 months
follow up remains well.
Conclusion
The production of reactive oxygen metabolites is critical
for the elimination of a variety of pathogens including
Staphylococcus aureus, Aspergillus, and Burkholderia cepacia
complex (Bcc). Over the last 20 years bacteria belonging to
the Bcc have emerged as an important opportunistic
human pathogen. The major clinical interest has focused
on pulmonary infections in cystic fibrosis with Burkholde-
ria cenocepacia and Burkholderia multivorans as accounting
Table 1: Liver function and full blood count results
Laboratory Findings Initial assessment After 2 days of prednisolone Admission for splenectomy On treatment
Albumin (g/l) 29 31 36 44
Bilirubin (μmol/l) 52 25 26 21
Alkaline Phosphatase (IU/l) 2191 1345 966 578
Alanine Transferase (IU/l) 114 89 57 287
Haemoglobin (g/dl) 9.0 8.6 9.8 16.6
White cell count (109/l) 2.2 4.4 1.3 5.0
Neutrophils (109/l) 1.47 3.00 0.76 4.0
Lymphocytes (109/l) 0.43 0.91 0.31 0.51
Platelets (109/l) 223 316 127 162BMC Clinical Pathology 2007, 7:1 http://www.biomedcentral.com/1472-6890/7/1
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for the majority of infections [5]. However, its pathogenic-
ity is not limited to cystic fibrosis patients and CGD
patients have been identified as a vulnerable group. Bcc
bacteria are intrinsically resistant to non-oxidative killing
by neutrophils, thus making these patients susceptible to
infection. In CGD patients. Bcc pneumonia and septicae-
mia are life threatening and have been associated with
fatal outcomes [6]. It is an rare infection in healthy
patients, and its isolation should be prompt a search for
evidence of immunodeficiency.
In addition to their increased susceptibility to infection,
patients with CGD are also prone to a variety of inflam-
matory and/or rheumatic diseases, which in some cases
may be the first clinical manifestations leading to diagno-
sis [7]. The common inflammatory complications include
cutaneous granulomas, inflammatory bowel disease sim-
ilar to Crohn's disease and a lupus-like syndrome. These
inflammatory complications typically respond rapidly to
systemic steroid therapy [8]. The finding of granulomas
may lead to confusion with other granulomatous condi-
tions including Crohn's disease and, particularly in the
presence of a raised serum angiotensin converting enzyme
(ACE), sarcoidosis [9,10]. However, serum ACE elevation
is associated with activation of the monocyte-macrophage
system and may be elevated in a variety of granulomatous
and non-granulomatous conditions including ulcerative
colitis, tuberculosis and alcoholic liver disease [11].
Although serum ACE is usually increased in sarcoidosis,
the test has low disease specificity and needs to be care-
fully interpreted in the light of the overall differential
diagnosis. Hepatic granulomas have previously been
reported in adult patients with CGD. In one series, six of
seven patients in which liver tissue was available for study
had histological evidence of granuloma [12]. In another
series 3 of 11 adult CGD patients studied had evidence of
granuloma formation on biopsy, one of whom later died
from decompensated liver cirrhosis secondary to granulo-
matosis [13].
Defects in NADPH oxidase are the underlying cause for
CGD. The functional NADPH oxidase complex is com-
posed of two membrane bound (gp91phox and gp22phox)
and two structural cytosolic proteins (gp47phox  and
gp67phox). The proteins gp91phox and gp22phox interact to
form a stable heterodimeric cytochrome complex and
deficiency of one is usually associated with deficiency of
the other protein. The majority of patients are X-linked
recessive due to mutations in gp91phox, with other forms
due to autosomal recessive mutations of the other compo-
nents each of which is encoded on a different chromo-
some [8]. Patients with X-linked CGD have a more severe
phenotype with earlier presentation, increase in infections
and increased incidence of chronic inflammatory mani-
festations. However some patients with X-linked CGD
have a gp91phox protein level ranging from 1% to 25% of
normal, so-called X91-. These patients often have variable
clinical symptoms and may present at an older age [14].
In this case the patients neutrophil burst test showed par-
tial shift suggesting there may be a small residual amount
of function. Western blots showed the presence of gp
22phox and gp91phox protein precursor but a decrease in
glycosylated forms (Figure 2). Genetic analysis confirmed
a missense mutation (937G>A) which has been previ-
ously identified as an X91- phenotype with detectable oxi-
dase activity, detectable p22 and slightly detectable gp91
Dihydrorhodamine (DHR) analysis of oxidation in peripheral  blood neutrophils Figure 1
Dihydrorhodamine (DHR) analysis of oxidation in 
peripheral blood neutrophils. In brief, after red blood cell 
lysis, neutrophils are loaded with DHR. After DHR loading, 
cells were stimulated for 15 mins with phorbol myristate 
acetate (PMA) and immediately analyzed by flow cytometry. 
DHR is a fluorescent dye taken up by neutrophils. When the 
neutrophils are stimulated and undergo respiratory burst the 
dye is oxidised with a shift of fluorescence to the right. 
Shown are (a) normal patient with unimodal shift of fluores-
cence after PMA stimulation; (b) the patient who has virtually 
absent shift in stimulated neutrophils consistent with X-
linked CGD; (c) the mother of the patient demonstrating 
dual population of neutrophils in peripheral blood of X-
linked CGD carriers.BMC Clinical Pathology 2007, 7:1 http://www.biomedcentral.com/1472-6890/7/1
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[15]. The patient had done relatively well with no infec-
tions until he was immunosuppressed with prednisolone
without antibiotic cover; the corticosteroid treatment may
have permitted the growth of B. multivorans. Corticoster-
oid treatment may have more severe consequences in
these patients and there are been reports in which patients
with undiagnosed CGD have been treated with corticos-
teroids with fatal consequences [16-18].
This case illustrates the importance of having a high clini-
cal suspicion for the diagnosis of immune deficiency in
the setting of presumed granulomatous disease and unu-
sual infections. Granulomas have been described in a vari-
ety of immunodeficiencies including common variable
immunodeficiency, Wiskott-Aldrich syndrome, ataxic tel-
angectasia and severe combined immunodeficiencies
[19]. In view of the importance of early diagnosis along
with genetic counselling for some families, testing to
exclude immunodeficiency should be considered at any
age when suspicious symptoms occur, especially in
patients with granulomas and atypical or recurrent infec-
tions.
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